Pharmacologic Interventions for Apathy in Patients with Alzheimer Disease - Cochrane ...
Jan 1, 2019 - Methylphenidate may improve apathy in select patients with AD (mean difference [MD] = –4.99 on the apathy evaluation scale; 95% confidence interval [CI], –9.55 to –0.43), although the clinical significance associated with these findings remains unclear and the evidence is considered low...
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2019/0101/p14.html
Appropriate Use of Polypharmacy for Older Patients - Cochrane for Clinicians - American...
Apr 1, 2013 - Multidisciplinary interventions that address polypharmacy decrease inappropriate prescribing and medication-related problems in patients 65 years and older, but it is not clear if they reduce hospital admissions or improve quality of life. Most interventions studied were led by ...
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2013/0401/p483.html
Exercise for Older Patients Who Are Acutely Hospitalized - Cochrane for Clinicians - ...
Jul 1, 2007 - The effects of exercise interventions on functional outcomes are unclear, but there is a trend toward functional improvement. Multidisciplinary interventions that include exercise also show several other benefits, including reduction in length of hospitalization and hospital costs; ...
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2007/0701/p69.html
Antidepressants in Older Persons - Cochrane for Clinicians - American Family Physician
Nov 1, 2006 - In older persons with depression, three classes of antidepressants are equally effective: selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, and tricyclic-like compounds. More patients taking classic tricyclic antidepressants stopped their medications because of...
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2006/1101/p1503.html
Are Atypical Antipsychotics Safe in Patients with Alzheimer's Disease? - Cochrane for ...
Aug 1, 2006 - Although the atypical antipsychotic medications risperidone (Risperdal) and olanzapine (Zyprexa) are modestly efficacious in reducing aggression, routine use is not justified. Both drugs are associated with serious adverse cerebrovascular events and extrapyramidal symptoms. Use of ...
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2006/0801/p414.html
navigate_before 1 navigate_next